Veterinary Practice’s Innovation Feature for February 2024 Covers FCGS Study
February 21, 2024 6:00 AM ET
Veterinary Practice covered our pivotal study of allogeneic stem cell therapy targeting feline chronic gingivostomatitis (FCGS) as its February 2024 Innovation Feature. The article is co-authored by Gallant CEO Dr. Linda Black and Valentine Williams.
From Veterinary Practice
Breakthroughs in Stem Cell Therapy for Refractory Feline Chronic Gingivostomatitis and Beyond
Gallant is redefining veterinary medicine with ready-to-use stem cell therapies that reduce inflammation, restore function, and fit seamlessly into everyday practice.
-
10865 Road to the Cure, Ste 101
San Diego, CA 92121 -
+1-855-442-5526
-
-
